FdaApplication
NDA 020873
Identifiers
- fda_app_no: NDA020873
Properties
| Property | Value |
|---|---|
| applicant_name | SANDOZ INC |
| application_type | NDA |
| approval_date | 2000-12-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ANGIOMAX | BIVALIRUDIN | 250MG/VIAL | INJECTABLE;INTRAVENOUS |
1 product